Safety and efficacy of a new non-foreshortening nitinol stent in malignant gastric outlet obstruction (DUONITI study): a prospective, multicenter study

Background and study aims: Gastric outlet obstruction (GOO) is a late complication of advanced gastric, periampullary, and duodenal malignancies. Palliation of obstruction is the primary aim of treatment in these patients. Self-expandable metal stents have emerged as a promising treatment option. Our aim was to investigate the safety and efficacy of a new non-foreshortening nitinol duodenal stent.

Patients and methods: A total of 52 patients with symptomatic malignant GOO were studied in this prospective multicenter cohort study. All patients received a D-Weave Niti-S duodenal stent (Taewoong Medical, Seoul, South Korea). Patients were followed up until withdrawal of informed consent or death.

Results: The cause of GOO was pancreatic cancer in the majority of patients (62 %). The technical and clinical success rates were 96 % and 77 %, respectively. The GOO Scoring System score improved significantly (P < 0.0001) when the scores before stenting were compared with the mean scores until death. Median survival was 82 days and stent patency was observed in 75 % for up to 190 days, accounting for death as a competing risk. In 13 patients (25 %) stent dysfunction occurred (tumor ingrowth in 11, stent migration in two). Over time, the body mass index, the World Health Organization performance score, and the EuroQol visual analog scale revealed a not significant change (P = 0.52, P = 0.43, and P = 0.15, respectively), whereas the global health status improved significantly (P = 0.001).

Conclusion: Placement of a new non-foreshortening nitinol enteral stent is safe and without major complications. This stent design produces significant relief of obstructive symptoms and improves quality of life in patients with incurable malignant GOO.

References

• 1 Jeurnink S M, van Eijck C H, Steyerberg E W et al. Stent versus gastrojejunostomy for the palliation of gastric outlet obstruction: a systematic review.  BMC Gastroenterol. 2007;  7 18
• 2 Del Piano M, Ballare M, Montino F et al. Endoscopy or surgery for malignant GI outlet obstruction?.  Gastrointest Endosc. 2005;  61 421-426
• 3 Johnsson E, Thune A, Liedman B. Palliation of malignant gastroduodenal obstruction with open surgical bypass or endoscopic stenting: clinical outcome and health economic evaluation.  World J Surg. 2004;  28 812-817
• 4 Mehta S, Hindmarsh A, Cheong E et al. Prospective randomized trial of laparoscopic gastrojejunostomy versus duodenal stenting for malignant gastric outflow obstruction.  Surg Endosc. 2006;  20 239-242
• 5 Watanapa P, Williamson R C. Surgical palliation for pancreatic cancer: developments during the past two decades.  Br J Surg. 1992;  79 8-20
• 6 Dormann A, Meisner S, Verin N, Wenk L A. Self-expanding metal stents for gastroduodenal malignancies: systematic review of their clinical effectiveness.  Endoscopy. 2004;  36 543-550
• 7 Holt A P, Patel M, Ahmed M M. Palliation of patients with malignant gastroduodenal obstruction with self-expanding metallic stents: the treatment of choice?.  Gastrointest Endosc. 2004;  60 1010-1017
• 8 Maetani I, Isayama H, Mizumoto Y. Palliation in patients with malignant gastric outlet obstruction with a newly designed enteral stent: a multicenter study.  Gastrointest Endosc. 2007;  66 355-360
• 9 van Hooft J E, Uitdehaag M J, Bruno M J et al. Efficacy and safety of the new WallFlex enteral stent in palliative treatment of malignant gastric outlet obstruction (DUOFLEX study): a prospective multicenter study.  Gastrointest Endosc. 2009;  69 1059-1066
• 10 Ludbrook J, Royse A G. Analysing clinical studies: principles, practice and pitfalls of Kaplan–Meier plots.  ANZ J Surg. 2008;  78 204-210 (including supplement 2, available from: http://www.heartweb.com.au/downloads/Ludbrooksupp2.xls Accessed: 19th January 2011)
• 11 Lee S M, Kang D H, Kim G H et al. Self-expanding metallic stents for gastric outlet obstruction resulting from stomach cancer: a preliminary study with a newly designed double-layered pyloric stent.  Gastrointest Endosc. 2007;  66 1206-1210
• 12 Kim J H, Song H Y, Shin J H et al. Metallic stent placement in the palliative treatment of malignant gastroduodenal obstructions: prospective evaluation of results and factors influencing outcome in 213 patients.  Gastrointest Endosc. 2007;  66 256-264
• 13 Telford J J, Carr-Locke D L, Baron T H et al. Palliation of patients with malignant gastric outlet obstruction with the enteral Wallstent: outcomes from a multicenter study.  Gastrointest Endosc. 2004;  60 916-920
• 14 Song H Y, Shin J H, Yoon C J et al. A dual expandable nitinol stent: experience in 102 patients with malignant gastroduodenal strictures.  J Vasc Interv Radiol. 2004;  15 1443-1449
• 15 Jung G S, Song H Y, Kang S G et al. Malignant gastroduodenal obstructions: treatment by means of a covered expandable metallic stent – initial experience.  Radiology. 2000;  216 758-763
• 16 Park K B, Do Y S, Kang W K et al. Malignant obstruction of gastric outlet and duodenum: palliation with flexible covered metallic stents.  Radiology. 2001;  219 679-683
• 17 Jeurnink S M, Steyerberg E W, van Hooft J E et al. Surgical gastrojejunostomy or endoscopic stent placement for the palliation of malignant gastric outlet obstruction (SUSTENT study): a multicenter randomized trial.  Gastrointest Endosc. 2010;  71 490-499
• 18 van Hooft J E, Dijkgraaf M G, Timmer R et al. Independent predictors of survival in patients with incurable malignant gastric outlet obstruction: a multicenter prospective observational study.  Scand J Gastroenterol. 2010;  45 1217-1222